Journal of Antimicrobial Chemotherapy : Impact Factor & More
eISSN: 1460-2091pISSN: 0305-7453
Share this on:
Aims and Scope of Journal of Antimicrobial Chemotherapy
The Journal of Antimicrobial Chemotherapy is a peer-reviewed medical journal which covers antimicrobial chemotherapy, including laboratory aspects and clinical use of antimicrobial agents. It is published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy and was established in 1975. In January 2015 J. Peter Donnelly (Radboud University Nijmegen Medical Centre) became the eighth editor-in-chief replacing Alan P. Johnson (Health Protection Agency, London, United Kingdom). The journal has had two previous publishers. All content is available for free after 12 months while authors also have the option to have their articles published immediately as open access. Less
Key Metrics
CiteScore 
9.4
H-Index
211
Impact Factor
5 - 10
Scite Index
0.86 5-Year SI
SJR
Q1Pharmacology
SNIP
1.65
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy Journal Specifications
| Overview | |
| Publisher | OXFORD UNIV PRESS |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1975 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Antimicrobial Chemotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Journal of Antimicrobial Chemotherapy
Evaluation of a novel lateral flow immunochromatographic assay, Certest ResisCheck\xae Carbapenemases, for the rapid detection and differentiation of carbapenemase in Gram-negative bacteria from bacterial culture
- 16 May 2026
- Journal of Antimicrobial Chemotherapy
Description of OXA-244 carbapenemase-producing Escherichia coli in farm animals in The Netherlands, 2024
- 15 May 2026
- Journal of Antimicrobial Chemotherapy
\u2018Leaving no stones unturned\u2019: up to 10 years results on the effectiveness, tolerability and metabolic safety of dolutegravir+lamivudine (DTG+3TC) as a switch regimen in the ODOACRE cohort
- 15 May 2026
- Journal of Antimicrobial Chemotherapy
Emulating a target trial of early compared with late initiation of appropriate antibiotic therapy for hospital-acquired monobacterial Gram-negative bloodstream infections
- 13 May 2026
- Journal of Antimicrobial Chemotherapy
Comparative nephrotoxicity of polymyxin B versus colistin: evidence from ensemble learning and propensity score matching.
- 5 May 2026
- The Journal of antimicrobial chemotherapy
Early adequate linezolid concentrations and clinical outcomes in confirmed Gram-positive infections: the role of therapeutic drug monitoring.
- 5 May 2026
- The Journal of antimicrobial chemotherapy
Evaluation of a novel lateral flow immunochromatographic assay, Certest ResisCheck\xae Carbapenemases, for the rapid detection and differentiation of carbapenemase in Gram-negative bacteria from bacterial culture
- 16 May 2026
- Journal of Antimicrobial Chemotherapy
Description of OXA-244 carbapenemase-producing Escherichia coli in farm animals in The Netherlands, 2024
- 15 May 2026
- Journal of Antimicrobial Chemotherapy
\u2018Leaving no stones unturned\u2019: up to 10 years results on the effectiveness, tolerability and metabolic safety of dolutegravir+lamivudine (DTG+3TC) as a switch regimen in the ODOACRE cohort
- 15 May 2026
- Journal of Antimicrobial Chemotherapy
Emulating a target trial of early compared with late initiation of appropriate antibiotic therapy for hospital-acquired monobacterial Gram-negative bloodstream infections
- 13 May 2026
- Journal of Antimicrobial Chemotherapy
Comparative nephrotoxicity of polymyxin B versus colistin: evidence from ensemble learning and propensity score matching.
- 5 May 2026
- The Journal of antimicrobial chemotherapy
Early adequate linezolid concentrations and clinical outcomes in confirmed Gram-positive infections: the role of therapeutic drug monitoring.
- 5 May 2026
- The Journal of antimicrobial chemotherapy
FAQs on Journal of Antimicrobial Chemotherapy
How long has Journal of Antimicrobial Chemotherapy been actively publishing? 
What is the publishing frequency of Journal of Antimicrobial Chemotherapy?
How many articles did Journal of Antimicrobial Chemotherapy publish last year?
What is the eISSN & pISSN for Journal of Antimicrobial Chemotherapy?
What is Citescore for Journal of Antimicrobial Chemotherapy?
What is the H Index for Journal of Antimicrobial Chemotherapy ?
What is SNIP score for Journal of Antimicrobial Chemotherapy?
What is the SJR for Journal of Antimicrobial Chemotherapy?
Who is the publisher of Journal of Antimicrobial Chemotherapy?
